Amedisys (AMED) Tops Q2 EPS by 12c

Amedisys (NASDAQ: AMED) reported Q2 EPS of $0.62, $0.12 better than the analyst estimate of $0.50. Revenue for the quarter came in at $378.8 million versus the consensus estimate of $380.7 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.

You May Also Be Interested In

• Simply Good Foods (SMPL) Tops Q3 EPS by 7c; offers outlook
• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• SEI Investments (SEIC) PT Raised to $115 at Morgan Stanley